LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Clinical trials for LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL trials appear
Sign up with your email to follow new studies for LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Three-Pronged attack tested against Tough-to-Treat blood cancer
Disease control CompletedThis study tested a combination of three medicines—ibrutinib, fludarabine, and pembrolizumab—for adults with a hard-to-treat form of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The goal was to see if using these drugs together could achieve a complete …
Matched conditions: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Phase: PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Breakthrough trial tests Chemo-Free approach for blood cancer
Disease control CompletedThis study tested a chemotherapy-free treatment approach for adults with previously untreated chronic lymphocytic leukemia (CLL), a type of blood cancer. All 135 participants received two targeted drugs (obinutuzumab and ibrutinib) for nine months. After this initial treatment, d…
Matched conditions: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Phase: PHASE2 • Sponsor: French Innovative Leukemia Organisation • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
First patients test new 'Double-Target' cancer drug
Disease control CompletedThis was the first human study of a new experimental drug called JNJ-75348780 for people with advanced non-Hodgkin lymphoma or chronic lymphocytic leukemia that has returned or stopped responding to other treatments. The main goals were to find a safe dose and understand the drug…
Matched conditions: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 16, 2026 15:23 UTC
-
New pill shows promise for Tough-to-Treat blood cancers
Disease control CompletedThis study tested an oral medication called LOXO-305 in Chinese adults with certain types of lymphoma or chronic leukemia that had returned or stopped responding to standard treatments. The main goal was to see how safe the drug was and how well it worked to control the cancer. R…
Matched conditions: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC